Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.

By D. Adam, J. Beard, T. Cleveland, J. Bell, A. Bradbury, J. Forbes, F. Fowkes, I. Gillepsie, C. Ruckley, G. Raab and 1 more. The Lancet, 2005

1,653 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/9b9101fc965044438c8103ef4571cf4e1267358a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. G. Moneta
2. R. Frykberg
3. M. H. Murad
4. Massimo F. Piepoli
5. Stephen Burgess
6. S. Thompson

Citations in the corpus

• Global vascular guidelines on the management of chronic limb-threatening ischemia (2019, methodology): “endovascular-first with a bypass surgery-first strategy in limb-threatening ischemia due to infrainguinal disease.(159,421) BASIL was conducted across 27 hospitals in”
• 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease (2016, methodology): “V A A uthor M anuscript V A A uthor M anuscript V A A uthor M anuscript Appendix 3 Abbreviations AAA = abdominal aortic aneurysm ABI = ankle-brachial index ALI = acute limb ischemia CAD = coronary artery disease CLI = critical limb ischemia CTA = computed tomography angiography DAPT = dual antiplate”
• High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study (2006, background): “It is unclear at what degree of peripheral ischaemia intervention is cost-effective and which procedure—bypass or endovascular intervention—should be performed [29, 30].”
• The management of diabetic foot: A clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. (2016, background): “Both open surgical bypass and endovascular revascularization can have significant shortterm and long-term complications.(39) Indications for arterial revascularization should be based on the standard indications of severe claudication, rest pain, and tissue loss.”
• Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). (2007, result): “This contrasts a recent randomized study of 452 patients which demonstrated no difference in amputation-free survival at 6 months; however, surgery was somewhat more expensive.(201) Medical treatment after PTA and stent placement is recommended to prevent early failure because of thrombosis at the s”